R. G. Wiewrodt (Muenster, Germany), I. Kalomenidis (Marousi, Greece)
LSC 2010 Abstract: Mesothelioma cell proliferation is controlled by mitogen activated protein kinase Erk1/2 and p38 and subsequent C/EBP-β activation
J. Zhong, M. Tamm, D. Lardinois, M. Roth (Switzerland)
|   |
Osteopontin of either host or tumor origin critically affects malignant pleural effusion formation
I. Psallidas, G. Stathopoulos, C. Moschos, A. Kollintza, K. Karabela, D. Simoes, S. Papiris, I. Kalomenidis (Haidari, Athens, Greece)
| |
Dissecting the mTOR pathway in malignant pleural mesothelioma
Y. Pignochino, S. Inghilleri, M. Zorzetto, M. Luisetti, P. Morbini, M. Aglietta, E. Pozzi, G. Stella (Candiolo, Pavia, Italy)
|  |
All-trans-retinoic acid inhibits tumor growth of malignant pleural mesothelioma in mice
C. Tabata, N. Hirayama, A. Yasumitsu, S. Yamada, A. Murakami, K. Tamura, T. Terada, K. Kuribayashi, K. Fukuoka, T. Nakano (Nishinomiya, Japan)
| |
Effects of mTOR Inhibition in malignant mesothelioma
A. Mohamed, M. A. Hoda, C. Pirker, P. Heffeter, B. Ghanim, B. Hegedus, W. Klepetko, W. Berger (Austria)
| |
Inhibition of phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase prevents malignant pleural mesothelioma cell growth
S. Miyoshi, H. Hamada, N. Hamaguchi, S. Hamaguchi, A. Kato, K. Irifune, R. Ito, J. Higaki (Toon, Japan)
| |
Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients
G. Johnen, I. Raiko, I. Sander, D. Weber, M. Raulf-Heimsoth, A. Gillissen, J. Kollmeier, A. Scherpereel, T. Brüning (Leipzig, Berlin, Germany; Lille, France)
| |
Proliferative intercellular signalling pathway in human malignant mesothelioma cells
J. Zhong, M. Tamm, D. Lardinois, M. Roth (Switzerland)
| |